Image

Global Cold Sore Treatment Market – Industry Trends and Forecast to 2029

  • Pharmaceutical
  • Upcoming Report
  • May 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Cold Sore Treatment Market, Strain Type (Herpes Simplex Type-1 Virus, Herpes Simplex Type-2 Virus), Therapeutics Type (Antiviral Agents, Analgesic Agents, Others), Drug Type (Branded, Generics), Dosage Form (Tablet, Capsule, Ointment, Others), Route of Administration (Oral, Topical, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) – Industry Trends and Forecast to 2029

 

Cold Sore Treatment Market

Market Analysis and Size                              

According to World Health Organization statistics, from 2020, around 3.7 million persons nationwide were infected with HSV 1. Direct contact with infected skin or saliva transmits the HSV-1 virus. Primary infection can produce a fever, aching gums, a sore throat, and swollen or irritated glands in the neck in children. The virus then becomes dormant in nerve roots close to the affected skin. The virus only rarely, if ever, reactivates in certain persons. Recurrences of the virus, known as secondary herpes episodes, can occur in certain people, resulting in cold sores. While the exact reason of reactivation has yet to be discovered, a range of factors, such as stress, dental treatment, illness, lip trauma, or sun exposure, might trigger an outbreak.

Data Bridge Market Research analyses that the cold sore treatment market was valued at USD 825.24 million in 2021 and is expected to reach USD 1,376.06 million by 2029, registering a CAGR of 6.60% during the forecast period of 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2014 - 2019)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Strain Type (Herpes Simplex Type-1 Virus, Herpes Simplex Type-2 Virus), Therapeutics Type (Antiviral Agents, Analgesic Agents, Others), Drug Type (Branded, Generics), Dosage Form (Tablet, Capsule, Ointment, Others), Route of Administration (Oral, Topical, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Pfizer Inc. (U.S.), GlaxoSmithKline plc (U.K.), Novartis AG (Switzerland), Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Sanofi (France), AstraZeneca (U.K.), Johnson & Johnson Private Limited (U.S.), Merck & Co., Inc. (U.S.),  F. Hoffmann-La Roche Ltd. (Switzerland), Cipla Inc. (U.S.), Hologic, Inc. (U.S.), BD (U.S.), Bristol-Myers Squibb Company (U.S.), Gilead Sciences, Inc. (U.S.), Bayer AG (Germany), Eli Lilly and Company (U.S.), Sun Pharmaceutical Industries Ltd. (India), Aurobindo Pharma (India), Lupin (India), Bausch Health Companies Inc. (Canada)

Market Opportunities

 

  • Lack of drug calls for new medicine
  • Technological advancement

Market Definition

A cold sore is a fluid-filled blister that occurs on the lips or around the mouth. Fever blisters, oral herpes, and herpes labialis are all terms used to describe cold sores. Herpes simplex is the virus that causes them. Herpes simplex virus 1 is the most prevalent strain of the virus that causes cold sores. Antiviral ointments, including acyclovir and penciclovir , are applied on sores as part of the treatment. These may work for some people, but they are frequently ineffective. Antiviral oral drugs such as famciclovir, acyclovir and valacyclovir can help reduce the duration and severity of sores. Symptoms may be relieved by applying over-the-counter pain relievers to the sores (topical). Anti-inflammatory drugs could potentially be beneficial.

Cold Sore Treatment Market Dynamics

Drivers

  • High prevalence rate of HSV infection

The rising prevalence of HSV infection across the globe will act as a major driver that will result in the expansion of the market's growth rate. In persons with long-term or chronic conditions, HSV increases the chance of acquiring and transmitting HIV infection and can cause significant complications such as encephalitis and keratitis. This, combined with the rising number of patients with chronic conditions, is one of the major factors driving the demand for HSV therapy worldwide.

  • Increasing investment for healthcare infrastructure

Another significant factor influencing the growth rate of cold sore treatment market is the rising healthcare expenditure which helps in improving its infrastructure. Also, various government organizations aims to improve the healthcare infrastructure by increasing funding and this will further influence the market dynamics.

Furthermore, a surging number of government initiatives to spread awareness and increase the geriatric population will expand the cold sore treatment market. Along with this, rising level of disposable income and growing government favorable initiatives will enhance the market's growth rate.

Opportunities

  • Lack of drug calls for new medicine  

The market's growth is fueled by lack of drug calls for new medicine. This will provide beneficial opportunities for the cold sore treatment market growth. There are only a few medicines available to treat cold sore on the market. This encourages pharmaceutical companies to produce new medications. The players are doing this by incorporating new technologies that will allow them to isolate the molecule for treatment. Furthermore, the issues of maintaining optimal pharmacokinetics and pharmacodynamics of medications are providing pharmaceutical firms with profitable opportunities.

Moreover, the market's growth is fueled by investment to develop advanced technologies and increase the number of emerging markets. These factors will provide beneficial opportunities for the cold sore treatment market growth.

Restraints/Challenges

On the other hand, the high cost associated with the treatment will obstruct the growth rate of the cold sore treatment market during 2022-2029. The lack of healthcare infrastructure in developing economies and strict regulatory scenario will challenge the cold sore treatment market. Additionally, lack of awareness among people and poor reimbursement policies will restrain and further impede the market's growth rate during the forecast period of 2022-2029.

This cold sore treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the cold sore treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

Cold sore treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period. 

COVID-19 Impact on Cold Sore Treatment Market

The pandemic of COVID-19 had a substantial impact on cold sore treatment market's growth. In many studies, the researcher established the link between the herpes simplex virus and the SARS-CoV-2 virus, which impacted the market positively due to the increased demand for antiviral drugs for treatment. The COVID-19 group had 2.81 percent of herpes simplex virus type-1 incidence compared to 0.77 percent in the hospital population odds ratio of 5.27. As a result, demand for herpes simplex virus therapy increased during the current pandemic. The COVID-19 pandemic, on the other hand, disrupted research and development of other medicines and drugs for chronic problems other than COVID-19, as well as treatment methods and pharmaceutical supply chains around the world, affecting the cold sore treatment market.

Recent Development

  • In July 2021, Devirex had announced the launch of lipivir. Devirex is beginning a new phase of development: what was developed in the lab will be gradually distributed to other markets. Lipivir(R) lip gel, which prevents cold sores, was accessible in pharmacies, drugstores, beauty spas, and online in early 2021 in Switzerland and Austria after hundreds of hours of creation, research, and analysis.

Global Cold Sore Treatment Market Scope

The cold sore treatment market is segmented on the basis of strain type, therapeutics type, drug type, dosage form, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Strain Type

  • Herpes Simplex Type-1 Virus
  • Herpes Simplex Type-2 Virus

Therapeutics Type

  • Antiviral Agents
  • .Acyclovir
  • Valacyclovir
  • Famciclovir
  • Penciclovir
  • Analgesic Agents
  • Others
  • Lysine
  • Rhubarb and sage
  • Propolis

Drug Type

  • Branded
  • Generics

Dosage Form

  • Tablet
  • Capsule
  • Ointment
  • Others

Route of Administration

  • Oral
  • Topical
  • Others

End-Users

  • Hospitals
  • Specialty Clinics
  • Homecare
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others

Cold Sore Treatment Market Regional Analysis/Insights

The cold sore treatment market is analysed and market size insights and trends are provided by country, strain type, therapeutics type, drug type, dosage form, route of administration, end-users and distribution channel as referenced above.

The countries covered in the cold sore treatment market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates the cold sore treatment market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the growing target population and rising healthcare expenditure will further propel the market's growth rate in this region. Additionally, the presence of major key players and rising consumer's awareness about the STD diseases will further propel the market's growth rate in this region.

Asia-Pacific is expected to be the fastest-growing region during the forecast period of 2022-2029 due to growing number of patient population in this region. Also, development of healthcare infrastructure and rising government initiatives will further propel the market's growth rate in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Cold Sore Treatment Market Share Analysis

The cold sore treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to cold sore treatment market.

Some of the major players operating in the cold sore treatment market are:

  • Pfizer Inc. (U.S.)
  • GlaxoSmithKline plc (U.K.)
  • Novartis AG (Switzerland)
  • Mylan N.V. (U.S.)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Sanofi (France)
  • AstraZeneca (U.K.)
  • Johnson & Johnson Private Limited (U.S.)
  • Merck & Co., Inc. (U.S.)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Bayer AG (Germany)
  • Eli Lilly and Company (U.S.)
  • Sun Pharmaceutical Industries Ltd. (India)
  • Aurobindo Pharma (India)
  • Lupin (India)
  • Cipla Inc. (U.S.)
  • Hologic, Inc. (U.S.)
  • BD (U.S.)
  • Bristol-Myers Squibb Company (U.S.)
  • Gilead Sciences, Inc. (U.S.)
  • Bausch Health Companies Inc. (Canada)

Research Methodology: Global Cold Sore Treatment Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

LIST OF TABLES 

TABLE 1 GLOBALCOLD SORE TREATMENT MARKET, PIPELINE ANALYSIS

TABLE 2 GENERIC DRUGS USED FOR THE TREATMENT OF HSV (COLD SORES)

TABLE 3 GLOBAL COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 4 GLOBAL HERPES SIMPLEX TYPE 1 VIRUS IN COLD SORE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 5 GLOBAL HERPES SIMPLEX TYPE 2 VIRUS IN COLD SORE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 6 GLOBAL COLD SORE TREATMENT MARKET, BY THERAPEUTICS 2019-2028 (USD MILLION)

TABLE 7 GLOBAL ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY REGION 2019-2028 (USD MILLION)

TABLE 8 GLOBAL ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 9 GLOBAL ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 10 GLOBAL ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 11 GLOBAL OTHERS IN COLD SORE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 12 GLOBAL COLD SORE TREATMENT MARKET, BY DRUG TYPE 2019-2028 (USD MILLION)

TABLE 13 GLOBAL GENERICS IN COLD SORE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 14 GLOBAL GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 15 GLOBAL BRANDED IN COLD SORE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 16 GLOBAL BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 17 GLOBAL COLD SORE TREATMENT MARKET, BY DOSAGE TYPE 2019-2028 (USD MILLION)

TABLE 18 GLOBAL ORAL IN COLD SORE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 19 GLOBAL ORAL SEGMENT IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 20 GLOBAL TOPICAL SEGMENT IN COLD SORE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 21 GLOBAL TOPICAL SEGMENT IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 22 GLOBAL OTHERS IN COLD SORE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 23 GLOBAL COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 24 GLOBAL HOSPITALS IN COLD SORE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 25 GLOBAL HOSPITALS IN COLD SORE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 26 GLOBAL SPECIALTY CLINICS IN COLD SORE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 27 GLOBAL OTHERS IN COLD SORE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 28 GLOBAL COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 29 GLOBAL HOSPITALS PHARMACY IN COLD SORE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 30 GLOBAL ONLINE PHARMACY IN COLD SORE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 31 GLOBAL RETAIL PHARMACY IN COLD SORE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 32 GLOBAL COLD SORE TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 33 NORTH AMERICA COLD SORE TREATMENT MARKET, COUNTRY, 2021-2028 (USD MILLION)

TABLE 34 NORTH AMERICA COLD SORE TREATMENT MARKET, BY STRAIN TYPE, 2021-2028 (USD MILLION )

TABLE 35 NORTH AMERICA COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2021-2028 (USD MILLION)

TABLE 36 NORTH AMERICA ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2021-2028 (USD MILLION)

TABLE 37 NORTH AMERICA ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2021-2028 (USD MILLION)

TABLE 38 NORTH AMERICA COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2021-2028 (USD MILLION)

TABLE 39 NORTH AMERICA GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2021-2028 (USD MILLION)

TABLE 40 NORTH AMERICA BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2021-2028 (USD MILLION)

TABLE 41 NORTH AMERICA COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2021-2028 (USD MILLION)

TABLE 42 NORTH AMERICA ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2021-2028 (USD MILLION)

TABLE 43 NORTH AMERICA TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2021-2028 (USD MILLION)

TABLE 44 NORTH AMERICA COLD SORE TREATMENT MARKET, BY END USER, 2021-2028 (USD MILLION)

TABLE 45 NORTH AMERICA COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 46 U.S. COLD SORE TREATMENT MARKET, BY STRAIN TYPE , 2021-2028 (USD MILLION )

TABLE 47 U.S. COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2021-2028 (USD MILLION )

TABLE 48 U.S. ANTI-VIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2021-2028 (USD MILLION )

TABLE 49 U.S. ANALGESICS AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2021-2028 (USD MILLION)

TABLE 50 U.S. COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2021-2028 (USD MILLION)

TABLE 51 U.S. GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2021-2028 (USD MILLION)

TABLE 52 U.S. BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE , 2021-2028 (USD MILLION)

TABLE 53 U.S. COLD SORE TREATMENT MARKET, BY DOSAGE TYPE , 2021-2028 (USD MILLION)

TABLE 54 U.S. ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE , 2021-2028 (USD MILLION)

TABLE 55 U.S. TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2018-2027 (USD MILLION)

TABLE 56 U.S. COLD SORE TREATMENT MARKET, BY END USER, 2021-2028 (USD MILLION)

TABLE 57 U.S. COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 58 CANADA COLD SORE TREATMENT MARKET, BY TESTING TYPE, 2021-2028 (USD MILLION )

TABLE 59 CANADA COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2021-2028 (USD MILLION )

TABLE 60 CANADA ANTI-VIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2021-2028 (USD MILLION )

TABLE 61 CANADA ANALGESICS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2021-2028 (USD MILLION)

TABLE 62 CANADA COLD SORE TREATMENT MARKET, BY DRUG TYPE , 2021-2028 (USD MILLION)

TABLE 63 CANADA GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE TYPE, 2021-2028 (USD MILLION)

TABLE 64 CANADA BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2021-2028 (USD MILLION)

TABLE 65 CANADA COLD SORE TREATMENT MARKET, BY DOSAGE TYPE , 2021-2028 (USD MILLION)

TABLE 66 CANADA ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE , 2021-2028 (USD MILLION)

TABLE 67 CANADA TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE , 2021-2028 (USD MILLION)

TABLE 68 CANADA COLD SORE TREATMENT MARKET, BY END USER, 2021-2028 (USD MILLION)

TABLE 69 CANADA COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 70 MEXICO COLD SORE TREATMENT MARKET, BY STRAIN TYPE, 2021-2028 (USD MILLION )

TABLE 71 MEXICO COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2021-2028 (USD MILLION )

TABLE 72 MEXICO ANTI-VIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2021-2028 (USD MILLION )

TABLE 73 MEXICO ANALGESICS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2021-2028 (USD MILLION)

TABLE 74 MEXICO COLD SORE TREATMENT MARKET, BY DRUG TYPE , 2021-2028 (USD MILLION)

TABLE 75 MEXICO GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2021-2028 (USD MILLION)

TABLE 76 MEXICO BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2021-2028 (USD MILLION)

TABLE 77 MEXICO COLD SORE TREATMENT MARKET, BY DOSAGE TYPE , 2021-2028 (USD MILLION)

TABLE 78 MEXICO ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE , 2021-2028 (USD MILLION)

TABLE 79 MEXICO TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE , 2021-2028 (USD MILLION)

TABLE 80 MEXICO COLD SORE TREATMENT MARKET, BY END USER, 2021-2028 (USD MILLION)

TABLE 81 MEXICO COLD SORE TREATMENT MARKET, BY DISTRIBUTION TYPE, 2021-2028 (USD MILLION)

TABLE 82 EUROPE COLD SORE MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 83 EUROPE COLD SORE MARKET, BY STRAIN, 2019-2028 (USD MILLION)

TABLE 84 EUROPE COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 85 EUROPE ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 86 EUROPE ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 87 EUROPE COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 88 EUROPE GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 89 EUROPE BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 90 EUROPE COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 91 EUROPE ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 92 EUROPE TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 93 EUROPE COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 94 EUROPE COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 95 GERMANY COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 96 GERMANY COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 97 GERMANY ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 98 GERMANY ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 99 GERMANY COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 100 GERMANY GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 101 GERMANY BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 102 GERMANY COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 103 GERMANY ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 104 GERMANY TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 105 GERMANY COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 106 GERMANY COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 107 FRANCE COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 108 FRANCE COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 109 FRANCE ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 110 FRANCE ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 111 FRANCE COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 112 FRANCE GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 113 FRANCE BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 114 FRANCE COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 115 FRANCE ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 116 FRANCE TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 117 FRANCE COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 118 FRANCE COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 119 U.K. COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 120 U.K. COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 121 U.K. ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 122 U.K. ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 123 U.K. COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 124 U.K. GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 125 U.K. BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 126 U.K. COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 127 U.K. ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 128 U.K. TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 129 U.K. COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 130 U.K. COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 131 ITALY COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 132 ITALY COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 133 ITALY ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 134 ITALY ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 135 ITALY COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 136 ITALY GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 137 ITALY BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 138 ITALY COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 139 ITALY ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 140 ITALY TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 141 ITALY COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 142 ITALY COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 143 SPAIN COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 144 SPAIN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 145 SPAIN ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 146 SPAIN ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 147 SPAIN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 148 SPAIN GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 149 SPAIN BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 150 SPAIN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 151 SPAIN ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 152 SPAIN TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 153 SPAIN COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 154 SPAIN COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 155 RUSSIA COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 156 RUSSIA COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 157 RUSSIA ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 158 RUSSIA ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 159 RUSSIA COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 160 RUSSIA GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 161 RUSSIA BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 162 RUSSIA COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 163 RUSSIA ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 164 RUSSIA TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 165 RUSSIA COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 166 RUSSIA COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 167 SWITZERLAND COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 168 SWITZERLAND COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 169 SWITZERLAND ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 170 SWITZERLAND ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 171 SWITZERLAND COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 172 SWITZERLAND GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 173 SWITZERLAND BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 174 SWITZERLAND COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 175 SWITZERLAND ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 176 SWITZERLAND TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 177 SWITZERLAND COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 178 SWITZERLAND COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 179 NETHERLAND COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 180 NETHERLAND COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 181 NETHERLAND ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 182 NETHERLAND ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 183 NETHERLAND COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 184 NETHERLAND GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 185 NETHERLAND BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 186 NETHERLAND COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 187 NETHERLAND ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 188 NETHERLAND TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 189 NETHERLAND COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 190 NETHERLAND COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 191 TURKEY COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 192 TURKEY COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 193 TURKEY ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 194 TURKEY ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 195 TURKEY COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 196 TURKEY GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 197 TURKEY BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 198 TURKEY COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 199 TURKEY ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 200 TURKEY TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 201 TURKEY COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 202 TURKEY COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 203 IRELAND COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 204 IRELAND COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 205 IRELAND ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 206 IRELAND ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 207 IRELAND COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 208 IRELAND GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 209 IRELAND BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 210 IRELAND COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 211 IRELAND ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 212 IRELAND TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 213 IRELAND COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 214 IRELAND COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 215 BELGIUM COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 216 BELGIUM COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 217 BELGIUM ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 218 BELGIUM ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 219 BELGIUM COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 220 BELGIUM GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 221 BELGIUM BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 222 BELGIUM COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 223 BELGIUM ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 224 BELGIUM TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 225 BELGIUM COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 226 BELGIUM COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 227 POLAND COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 228 POLAND COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 229 POLAND ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 230 POLAND ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 231 POLAND COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 232 POLAND GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 233 POLAND BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 234 POLAND COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 235 POLAND ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 236 POLAND TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 237 POLAND COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 238 POLAND COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 239 AUSTRIA COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 240 AUSTRIA COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 241 AUSTRIA ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 242 AUSTRIA ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 243 AUSTRIA COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 244 AUSTRIA GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 245 AUSTRIA BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 246 AUSTRIA COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 247 AUSTRIA ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 248 AUSTRIA TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 249 AUSTRIA COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 250 AUSTRIA COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 251 NORWAY COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 252 NORWAY COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 253 NORWAY ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 254 NORWAY ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 255 NORWAY COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 256 NORWAY GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 257 NORWAY BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 258 NORWAY COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 259 NORWAY ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 260 NORWAY TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 261 NORWAY COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 262 NORWAY COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 263 HUNGARY COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 264 HUNGARY COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 265 HUNGARY ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 266 HUNGARY ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 267 HUNGARY COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 268 HUNGARY GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 269 HUNGARY BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 270 HUNGARY COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 271 HUNGARY ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 272 HUNGARY TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 273 HUNGARY COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 274 HUNGARY COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 275 LITHUANIA COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 276 LITHUANIA COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 277 LITHUANIA ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 278 LITHUANIA ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 279 LITHUANIA COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 280 LITHUANIA GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 281 LITHUANIA BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 282 LITHUANIA COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 283 LITHUANIA ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 284 LITHUANIA TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 285 LITHUANIA COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 286 LITHUANIA COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 287 REST OF EUROPE COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 288 ASIA PACIFIC COLD SORE MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 289 ASIA PACIFIC COLD SORE MARKET, BY STRAIN, 2019-2028 (USD MILLION)

TABLE 290 ASIA PACIFIC COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 291 ASIA PACIFIC ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 292 ASIA PACIFIC ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 293 ASIA PACIFIC COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 294 ASIA PACIFIC GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 295 ASIA PACIFIC BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 296 ASIA PACIFIC COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 297 ASIA PACIFIC ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 298 ASIA PACIFIC TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 299 ASIA PACIFIC COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 300 ASIA PACIFIC COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 301 CHINA COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 302 CHINA COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 303 CHINA ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 304 CHINA ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 305 CHINA COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 306 CHINA GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 307 CHINA BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 308 CHINA COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 309 CHINA ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 310 CHINA TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 311 CHINA COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 312 CHINA COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 313 JAPAN COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 314 JAPAN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 315 JAPAN ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 316 JAPAN ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 317 JAPAN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 318 JAPAN GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 319 JAPAN BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 320 JAPAN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 321 JAPAN ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 322 JAPAN TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 323 JAPAN COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 324 JAPAN COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 325 INDIA COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 326 INDIA COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 327 INDIA ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 328 INDIA ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 329 INDIA COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 330 INDIA GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 331 INDIA BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 332 INDIA COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 333 INDIA ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 334 INDIA TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 335 INDIA COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 336 INDIA COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 337 PERU COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 338 PERU COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 339 AUSTRALIA ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 340 AUSTRALIA ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 341 AUSTRALIA COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 342 AUSTRALIA GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 343 AUSTRALIA BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 344 AUSTRALIA COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 345 AUSTRALIA ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 346 AUSTRALIA TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 347 AUSTRALIA COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 348 AUSTRALIA COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 349 SOUTH KOREA COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 350 SOUTH KOREA COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 351 SOUTH KOREA ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 352 SOUTH KOREA ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 353 SOUTH KOREA COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 354 SOUTH KOREA GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 355 SOUTH KOREA BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 356 SOUTH KOREA COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 357 SOUTH KOREA ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 358 SOUTH KOREA TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 359 SOUTH KOREA COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 360 SOUTH KOREA COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 361 SINGAPORE COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 362 SINGAPORE COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 363 SINGAPORE ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 364 SINGAPORE ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 365 SINGAPORE COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 366 SINGAPORE GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 367 SINGAPORE BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 368 SINGAPORE COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 369 SINGAPORE ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 370 SINGAPORE TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 371 SINGAPORE COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 372 SINGAPORE COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 373 MALAYSIA COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 374 MALAYSIA COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 375 MALAYSIA ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 376 MALAYSIA ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 377 MALAYSIA COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 378 MALAYSIA GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 379 MALAYSIA BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 380 MALAYSIA COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 381 MALAYSIA ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 382 MALAYSIA TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 383 MALAYSIA COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 384 MALAYSIA COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 385 PHILIPPINESS COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 386 PHILIPPINESS COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 387 PHILIPPINESS ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 388 PHILIPPINESS ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 389 PHILIPPINESS COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 390 PHILIPPINESS GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 391 PHILIPPINESS BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 392 PHILIPPINESS COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 393 PHILIPPINESS ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 394 PHILIPPINESS TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 395 PHILIPPINESS COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 396 PHILIPPINESS COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 397 INDONESIA COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 398 INDONESIA COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 399 INDONESIA ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 400 INDONESIA ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 401 INDONESIA COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 402 INDONESIA GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 403 INDONESIA BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 404 INDONESIA COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 405 INDONESIA ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 406 INDONESIA TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 407 INDONESIA COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 408 INDONESIA COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 409 THAILAND COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 410 THAILAND COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 411 THAILAND ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 412 THAILAND ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 413 THAILAND COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 414 THAILAND GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 415 THAILAND BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 416 THAILAND COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 417 THAILAND ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 418 THAILAND TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 419 THAILAND COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 420 THAILAND COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 421 VIETNAM COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 422 VIETNAM COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 423 VIETNAM ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 424 VIETNAM ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 425 VIETNAM COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 426 VIETNAM GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 427 VIETNAM BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 428 VIETNAM COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 429 VIETNAM ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 430 VIETNAM TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 431 VIETNAM COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 432 VIETNAM COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 433 REST OF ASIA-PACIFIC COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 434 SOUTH AMERICA COLD SORE MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 435 SOUTH AMERICA COLD SORE MARKET, BY STRAIN, 2019-2028 (USD MILLION)

TABLE 436 SOUTH AMERICA COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 437 SOUTH AMERICA ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 438 SOUTH AMERICA ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 439 SOUTH AMERICA COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 440 SOUTH AMERICA GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 441 SOUTH AMERICA BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 442 SOUTH AMERICA COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 443 SOUTH AMERICA ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 444 SOUTH AMERICA TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 445 SOUTH AMERICA COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 446 SOUTH AMERICA COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 447 BRAZIL COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 448 BRAZIL COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 449 BRAZIL ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 450 BRAZIL ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 451 BRAZIL COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 452 BRAZIL GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 453 BRAZIL BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 454 BRAZIL COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 455 BRAZIL ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 456 BRAZIL TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 457 BRAZIL COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 458 BRAZIL COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 459 ARGENTINA COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 460 ARGENTINA COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 461 ARGENTINA ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 462 ARGENTINA ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 463 ARGENTINA COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 464 ARGENTINA GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 465 ARGENTINA BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 466 ARGENTINA COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 467 ARGENTINA ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 468 ARGENTINA TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 469 ARGENTINA COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 470 ARGENTINA COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 471 PERU COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 472 PERU COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 473 PERU ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2019-2028 (USD MILLION)

TABLE 474 PERU ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2019-2028 (USD MILLION)

TABLE 475 PERU COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 476 PERU GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 477 PERU BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 478 PERU COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 479 PERU ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 480 PERU TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2019-2028 (USD MILLION)

TABLE 481 PERU COLD SORE TREATMENT MARKET, BY END USER 2019-2028 (USD MILLION)

TABLE 482 PERU COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 483 REST OF SOUTH AMERICA COLD SORE TREATMENT MARKET, BY STRAIN TYPE 2019-2028 (USD MILLION)

TABLE 484 MIDDLE EAST & AFRICA COLD SORE TREATMENT MARKET, COUNTRY, 2021-2028 (USD MILLION)

TABLE 485 MIDDLE EAST & AFRICA COLD SORE TREATMENT MARKET, BY STRAIN TYPE, 2021-2028 (USD MILLION )

TABLE 486 MIDDLE EAST & AFRICA COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2021-2028 (USD MILLION)

TABLE 487 MIDDLE EAST & AFRICA ANTIVIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2021-2028 (USD MILLION)

TABLE 488 MIDDLE EAST & AFRICA ANALGESIC AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2021-2028 (USD MILLION)

TABLE 489 MIDDLE EAST & AFRICA COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2021-2028 (USD MILLION)

TABLE 490 MIDDLE EAST & AFRICA GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2021-2028 (USD MILLION)

TABLE 491 MIDDLE EAST & AFRICA BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2021-2028 (USD MILLION)

TABLE 492 MIDDLE EAST & AFRICA COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2021-2028 (USD MILLION)

TABLE 493 MIDDLE EAST & AFRICA ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2021-2028 (USD MILLION)

TABLE 494 MIDDLE EAST & AFRICA TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2021-2028 (USD MILLION)

TABLE 495 MIDDLE EAST & AFRICA COLD SORE TREATMENT MARKET, BY END USER, 2021-2028 (USD MILLION)

TABLE 496 MIDDLE EAST & AFRICA COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 497 SOUTH AFRICA COLD SORE TREATMENT MARKET, BY STRAIN TYPE , 2021-2028 (USD MILLION )

TABLE 498 SOUTH AFRICA COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2021-2028 (USD MILLION )

TABLE 499 SOUTH AFRICA ANTI-VIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2021-2028 (USD MILLION )

TABLE 500 SOUTH AFRICA ANALGESICS AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2021-2028 (USD MILLION)

TABLE 501 SOUTH AFRICA COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2021-2028 (USD MILLION)

TABLE 502 SOUTH AFRICA GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2021-2028 (USD MILLION)

TABLE 503 SOUTH AFRICA BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE , 2021-2028 (USD MILLION)

TABLE 504 SOUTH AFRICA COLD SORE TREATMENT MARKET, BY DOSAGE TYPE , 2021-2028 (USD MILLION)

TABLE 505 SOUTH AFRICA ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE , 2021-2028 (USD MILLION)

TABLE 506 SOUTH AFRICA TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE, 2018-2027 (USD MILLION)

TABLE 507 SOUTH AFRICA COLD SORE TREATMENT MARKET, BY END USER, 2021-2028 (USD MILLION)

TABLE 508 SOUTH AFRICA COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 509 EGYPT COLD SORE TREATMENT MARKET, BY TESTING TYPE, 2021-2028 (USD MILLION )

TABLE 510 EGYPT COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2021-2028 (USD MILLION )

TABLE 511 EGYPT ANTI-VIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2021-2028 (USD MILLION )

TABLE 512 EGYPT ANALGESICS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2021-2028 (USD MILLION)

TABLE 513 EGYPT COLD SORE TREATMENT MARKET, BY DRUG TYPE , 2021-2028 (USD MILLION)

TABLE 514 EGYPT GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE TYPE, 2021-2028 (USD MILLION)

TABLE 515 EGYPT BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2021-2028 (USD MILLION)

TABLE 516 EGYPT COLD SORE TREATMENT MARKET, BY DOSAGE TYPE , 2021-2028 (USD MILLION)

TABLE 517 EGYPT ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE , 2021-2028 (USD MILLION)

TABLE 518 EGYPT TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE , 2021-2028 (USD MILLION)

TABLE 519 EGYPT COLD SORE TREATMENT MARKET, BY END USER, 2021-2028 (USD MILLION)

TABLE 520 EGYPT COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 521 SAUDI ARABIA COLD SORE TREATMENT MARKET, BY STRAIN TYPE, 2021-2028 (USD MILLION )

TABLE 522 SAUDI ARABIA COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2021-2028 (USD MILLION )

TABLE 523 SAUDI ARABIA ANTI-VIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2021-2028 (USD MILLION )

TABLE 524 SAUDI ARABIA ANALGESICS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2021-2028 (USD MILLION)

TABLE 525 SAUDI ARABIA COLD SORE TREATMENT MARKET, BY DRUG TYPE , 2021-2028 (USD MILLION)

TABLE 526 SAUDI ARABIA GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2021-2028 (USD MILLION)

TABLE 527 SAUDI ARABIA BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2021-2028 (USD MILLION)

TABLE 528 SAUDI ARABIA COLD SORE TREATMENT MARKET, BY DOSAGE TYPE , 2021-2028 (USD MILLION)

TABLE 529 SAUDI ARABIA ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE , 2021-2028 (USD MILLION)

TABLE 530 SAUDI ARABIA TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE , 2021-2028 (USD MILLION)

TABLE 531 SAUDI ARABIA COLD SORE TREATMENT MARKET, BY END USER, 2021-2028 (USD MILLION)

TABLE 532 SAUDI ARABIA COLD SORE TREATMENT MARKET, BY DISTRIBUTION TYPE, 2021-2028 (USD MILLION)

TABLE 533 ISRAEL COLD SORE TREATMENT MARKET, BY STRAIN TYPE, 2021-2028 (USD MILLION )

TABLE 534 ISRAEL COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2021-2028 (USD MILLION )

TABLE 535 ISRAEL ANTI-VIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2021-2028 (USD MILLION )

TABLE 536 ISRAEL ANALGESICS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2021-2028 (USD MILLION)

TABLE 537 ISRAEL COLD SORE TREATMENT MARKET, BY DRUG TYPE , 2021-2028 (USD MILLION)

TABLE 538 ISRAEL GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2021-2028 (USD MILLION)

TABLE 539 ISRAEL BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2021-2028 (USD MILLION)

TABLE 540 ISRAEL COLD SORE TREATMENT MARKET, BY DOSAGE TYPE , 2021-2028 (USD MILLION)

TABLE 541 ISRAEL ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE , 2021-2028 (USD MILLION)

TABLE 542 ISRAEL TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE , 2021-2028 (USD MILLION)

TABLE 543 ISRAEL COLD SORE TREATMENT MARKET, BY END USER, 2021-2028 (USD MILLION)

TABLE 544 ISRAEL COLD SORE TREATMENT MARKET, BY DISTRIBUTION TYPE, 2021-2028 (USD MILLION)

TABLE 545 UAE COLD SORE TREATMENT MARKET, BY STRAIN TYPE, 2021-2028 (USD MILLION )

TABLE 546 UAE COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2021-2028 (USD MILLION )

TABLE 547 UAE ANTI-VIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2021-2028 (USD MILLION )

TABLE 548 UAE ANALGESICS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2021-2028 (USD MILLION)

TABLE 549 UAE COLD SORE TREATMENT MARKET, BY DRUG TYPE , 2021-2028 (USD MILLION)

TABLE 550 UAE GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2021-2028 (USD MILLION)

TABLE 551 UAE BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2021-2028 (USD MILLION)

TABLE 552 UAE COLD SORE TREATMENT MARKET, BY DOSAGE TYPE , 2021-2028 (USD MILLION)

TABLE 553 UAE ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE , 2021-2028 (USD MILLION)

TABLE 554 UAE TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE , 2021-2028 (USD MILLION)

TABLE 555 UAE COLD SORE TREATMENT MARKET, BY END USER, 2021-2028 (USD MILLION)

TABLE 556 UAE COLD SORE TREATMENT MARKET, BY DISTRIBUTION TYPE, 2021-2028 (USD MILLION)

TABLE 557 KUWAIT COLD SORE TREATMENT MARKET, BY STRAIN TYPE, 2021-2028 (USD MILLION )

TABLE 558 KUWAIT COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2021-2028 (USD MILLION )

TABLE 559 KUWAIT ANTI-VIRAL AGENTS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS, 2021-2028 (USD MILLION )

TABLE 560 KUWAIT ANALGESICS IN COLD SORE TREATMENT MARKET, BY THERAPEUTICS , 2021-2028 (USD MILLION)

TABLE 561 KUWAIT COLD SORE TREATMENT MARKET, BY DRUG TYPE , 2021-2028 (USD MILLION)

TABLE 562 KUWAIT GENERICS IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2021-2028 (USD MILLION)

TABLE 563 KUWAIT BRANDED IN COLD SORE TREATMENT MARKET, BY DRUG TYPE, 2021-2028 (USD MILLION)

TABLE 564 KUWAIT COLD SORE TREATMENT MARKET, BY DOSAGE TYPE , 2021-2028 (USD MILLION)

TABLE 565 KUWAIT ORAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE , 2021-2028 (USD MILLION)

TABLE 566 KUWAIT TOPICAL IN COLD SORE TREATMENT MARKET, BY DOSAGE TYPE , 2021-2028 (USD MILLION)

TABLE 567 KUWAIT COLD SORE TREATMENT MARKET, BY END USER, 2021-2028 (USD MILLION)

TABLE 568 KUWAIT COLD SORE TREATMENT MARKET, BY DISTRIBUTION TYPE, 2021-2028 (USD MILLION)

TABLE 569 REST OF MIDDLE EAST & AFRICA COLD SORE TREATMENT MARKET, BY STRAIN TYPE, 2021-2028 (USD MILLION )

 

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions



Frequently Asked Questions

The market value for Cold Sore Treatment Market is expected USD 1,376.06 million by 2029.
The cold sore treatment market is to grow at a CAGR of 6.60% during the forecast period of 2022 to 2029
The cold sore treatment report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market.
The major players operating in the Cold Sore Treatment Market are Pfizer Inc. (U.S.), GlaxoSmithKline plc (U.K.), Novartis AG (Switzerland), Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Sanofi (France), AstraZeneca (U.K.), Johnson & Johnson Private Limited (U.S.), Merck & Co., Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Cipla Inc. (U.S.), Hologic, Inc. (U.S.), BD (U.S.), Bristol-Myers Squibb Company (U.S.), Gilead Sciences, Inc. (U.S.), Bayer AG (Germany), Eli Lilly and Company (U.S.), Sun Pharmaceutical Industries Ltd. (India), Aurobindo Pharma (India), Lupin (India), Bausch Health Companies Inc. (Canada).